Table 3. COVID-19 deaths among health care workers, clients and family members due to transmission during access to HIV services and HIV-related deaths that could be averted by these services per 10,000 clients.
Additional COVID-19 Deaths | HIV-Related Deaths Averted | ||||||
---|---|---|---|---|---|---|---|
HIV Service | Contact Model | Cooper/Smith | Covasim | Goals | HIV Synthesis | Optima HIV | EMOD |
VMMC | 0.01–0.24 | 0.004 | 0.098 | 19 (10–30) | 115 (-4-235) | 103 (4–223) | 92 (0–323) |
HIV testing | 0.00–0.17 | 0.152 | 0.004 | 22 (20–35) | 22 (17–26) | 22 (12–42) | 14 (6–22) |
Viral load testing | 0.00–0.17 | 0.152 | 0.004 | 44 (27–61) | 49 (39–275) | ||
PMTCT | 0.01–0.24 | 0.002 | 0.098 | 33 (0–100) | 44 (0–358) |
Note: Figures in parentheses represent 95% confidence bounds (95% confidence interval for mean across setting scenarios for HIV Synthesis). Ranges for the Contact Model are across 6 countries. Different models were applied to different countries as specified in methods section. The rate of mortality is the unweighted averaged across the countries for which the analysis was conducted.